Investigators assessed potential biomarkers associated with poorly controlled asthma among patients in Tunisia.
Results of a prospective cohort study revealed patients with asthma—and particularly those with uncontrolled asthma—have a high degree of reactive oxygen species (ROS) formation which causes considerable oxidative stress, authors wrote.
In addition, increased levels of malondialdehyde (MDA) and superoxide dismutase (SOD) activity, as well as reduced glutathione peroxidase (GPx) activity, serve as predictors of poorly controlled asthma, according to the findings published in the Journal of Clinical Laboratory Analysis.
Asthma symptoms can include wheezing, shortness or breath, chest tightness, and coughing, and although medication exists to appropriately control the condition, when uncontrolled, asthma can lead to severe disruptions in daily life.
“The sustained activation of phagocytic cells and inflammatory mediators in the airways of asthmatic patients lead to high levels of oxidative stress in the lungs,” researchers explained. “This increased oxidative stress affects mucus hypersecretion and alters capillary endothelium, which may cause a leak of reactive oxygen species (ROS) into the systemic circulation.”
In an effort to better understand oxidant and antioxidant status in patients with asthma compared with healthy controls, and to investigate any correlation with the level of asthma control, 60 patients were recruited from a Tunisian hospital between January and March of 2018.
All participants were over the age of 18, had received an asthma diagnosis at least 6 months prior and were treated with an inhaled corticosteroid oral or inhaled beta 2-agonist. Forty-eight individuals were included in the study as age- and sex-matched controls.
“Asthma is defined as ‘controlled’ if the ACT [Asthma Control Test] score is ≥20, ‘partly controlled’ if the ACT score is between 16 and 19, and ‘uncontrolled’ if the ACT score is ≤15,” researchers wrote.
Analyses revealed:
Researchers hypothesized the contrasting outcomes seen for AOPP and SOD, and no significant variation in AOPP levels, could be due to differences in lifestyle variations, dietary factors, or additional confounding influences.
Based on the findings, “we inferred that conditions of uncontrolled asthma strongly evoke oxidative damages,” they wrote. “According to the multivariate logistic regression analysis results, we concluded that plasma MDA level is a potential and predictive biomarker of asthma control level in patients with asthma.”
Analyses between patient subgroups also showed asthma is never completely controlled, even when patients are on medication. Additional studies among larger cohorts are warranted to validate results, authors concluded.
Reference
Ammar M, Bahloul N, Amri O, et al. Oxidative stress in patients with asthma and its relation to uncontrolled asthma. J Clin Lab Anal. Published online March 22, 2022. doi:10.1002/jcla.24345
Review: One-Shot Etranacogene Dezaparvovec Represents Game-Changing Gene Therapy for Hemophilia B
May 3rd 2024More than 20 years of gene therapy clinical research have led to etranacogene dezaparvovec’s use in hemophilia B, according to authors of a recent review—and it takes its place in a line of current and potentially many future genomic medicines for a range of diseases.
Read More
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More